< Practice Enhancement Programs / DYSIS
Clinical Trial Name:
DYSIS (Dyslipidemia International Survey)

Status: Closed Enrolment as of Oct 20th, 2008

FDA Clinical Trial number:
Epidemiological Cross-sectional Observational Study

Brief description:  
Epidemiological study sharing same protocol in various countries in Europe and Canada to estimate the prevalence of types of lipid abnormalities, and associated risks and relationship between the persistent lipid abnormalities and local known prevalence of CV morbidity and mortality.

Eligibility:  
Patients 45 years and older treated with Statin at the time of enrollment, Availability of fasting lipid profile while on Statins for at least 3 months.

Inclusion/exclusion criteria:
Patients 45 years and older treated with Statin at the time of enrollment, Availability of fasting lipid profile while on Statins for at least 3 months.

Sponsor(s):
Merck Frosst Canada Ltd.